Uterine Artery Embolization for XXXX : Percentage of Necrosis Predicts Midterm Clinical Recurrence.

@entity1 @entity1870 @entity39
PURPOSE: To evaluate the effect of degree of @entity39 after uterine artery embolization (UAE) on symptom recurrence at midterm clinical follow-up in @entity1 with @entity1870 . MATERIALS AND METHODS: @entity1 (N = 50) who underwent UAE for symptomatic @entity1870 were retrospectively analyzed. All @entity1 underwent contrast-enhanced magnetic resonance (MR) imaging at baseline and 3 months after UAE and were followed clinically for at least 18 months. The type of @entity1870 was classified as focal or diffuse. The uterine volume and the percentage of @entity39 after embolization were measured three-dimensionally on MR imaging. The percentage of the @entity39 cutoff point for predicting recurrence was estimated. @entity1 were divided into 2 groups according to the cutoff point. The rate of recurrence was compared between groups, and risk factors for recurrence were identified. RESULTS: During the follow-up period (range, 18-48 mo), symptom recurrence occurred in 12 of 50 @entity1 . A @entity39 cutoff point of 34.3% was calculated to predict recurrence (area under the curve = 0.721; 95% confidence interval [CI] = 0.577-0.839; P = .004). @entity1 with < 34.3% @entity39 (group A, n = 12) were at a significantly higher risk of recurrence than @entity1 with > 34.3% @entity39 (group B, n = 38; hazard ratio = 7.0; 95% CI = 2.2, 22.4; P = .001). Initial uterine volume and type of @entity1870 were not associated with recurrence. CONCLUSIONS: The percentage of @entity39 in @entity1 with @entity1870 after UAE may predict symptom recurrence at midterm follow-up. The cutoff percentage of @entity39 required to predict symptom recurrence was 34.3% in this study.
